econazole nitrate + triamcinolone acetonide

Stenide is a topical fixed-dose combination cream developed by Navana Pharmaceuticals, containing the broad-spectrum imidazole antifungal econazole nitrate (1%) and the synthetic corticosteroid triamcinolone acetonide (0.1%). Econazole nitrate exerts its antifungal effect by inhibiting lanosterol 14-alpha demethylase (CYP51), thereby disrupting ergosterol synthesis and compromising fungal cell membrane integrity. Triamcinolone acetonide acts as a glucocorticoid receptor agonist, suppressing local inflammatory responses, reducing capillary permeability, and alleviating symptoms such as redness, swelling, and itching. Stenide is indicated for the short-term treatment of inflammatory dermatomycoses and eczematous skin conditions complicated by or threatened by bacterial or fungal infections, including tinea pedis, tinea corporis, tinea cruris, and diaper dermatitis.

Brand names

StenideStenide Cream

Other names

econazole + triamcinoloneeconazole and triamcinoloneeconazole nitrate + triamcinolone acetonideeconazole nitrate and triamcinolone acetonidetriamcinolone + econazoletriamcinolone and econazoletriamcinolone acetonide + econazole nitratetriamcinolone acetonide and econazole nitrate